Live tape
Top 8, mentions 7d16,183MSFT3,160 mentions▲ +0.09GOOGL2,263 mentions▲ +0.05AAPL2,186 mentions▲ +0.07META2,133 mentions▲ +0.04SNDK1,899 mentions▲ +0.07NVDA1,636 mentions▲ +0.07SPCX1,617 mentions▲ +0.06AMZN1,289 mentions▲ +0.09

Equity · Healthcare

KYMR

Kymera Therapeutics, Inc. · NasdaqGM

$116.00 +1.75% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart Chart by TradingView
Track this symbol on TradingView

The chart above plots the price of KYMR over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 54 sessions over that window: $83.57 on 4 May 2026 through $116.00 on 17 July 2026. Finazon · prior-day close.

Market cap $9.5B
52-week range $38.00 – $119.06
Avg volume 307.8K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

KYMR insider trades

SEC Form 4 · last 90 days · newest reported trade 29 Jun 2026
Open-market buys 0
Open-market sells 9
Net sold $369.22M
Non-trade filings 1
Date Insider Type Shares Value
29 Jun 2026 Booth Bruce Director Sell 153,300 $16.56M
26 Jun 2026 Booth Bruce Director Sell 467,878 $51.60M
26 Jun 2026 BVF PARTNERS L P/IL Director Sell 1,630,658 $173.67M
25 Jun 2026 Booth Bruce Director Sell 548,321 $65.12M
24 Jun 2026 Booth Bruce Director Sell 134,720 $13.54M
23 Jun 2026 Booth Bruce Director Sell 1,408 $141K
22 Jun 2026 Booth Bruce Director Sell 278,128 $27.57M
18 Jun 2026 Booth Bruce Director Sell 115,056 $10.47M
17 Jun 2026 Booth Bruce Director Sell 116,812 $10.55M
Compensation mechanics (1 filing)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
17 Jun 2026 Booth Bruce Director Option exercise 11,741 $235K

KYMR reported financials

SEC EDGAR XBRL

KYMR reported revenue of $39.2M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$311.4M.

Figure Reported Period
Revenue $39.2M 31 Dec 2025 fiscal year
Net income −$311.4M 31 Dec 2025 fiscal year
Diluted EPS −$3.69 31 Dec 2025 fiscal year
Total assets $1.7B 31 Mar 2026 at period end
Total equity $1.5B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

KYMR earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-0.71 $34M
31 Dec 2025 FY 2025 $-3.69 $39M
30 Sep 2025 Q3 2025 $-0.94 $3M
30 Jun 2025 Q2 2025 $-0.95 $11M

Reported figures & scheduled dates · SEC EDGAR filings

KYMR institutional holders

SEC Form 13F

5 of the 45 institutional funds we track reported a KYMR position for the quarter ended 31 Mar 2026 — a combined $754.7M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) 8,657,242 $721.1M
Two Sigma Investments Held (±25%) −3.4% shares 256,501 $21.4M
Citadel Advisors Trimmed −25.8% shares 118,597 $9.9M
AQR Capital Management Added +70.8% shares 15,951 $1.3M
Man Group Trimmed −33.4% shares 13,334 $1.1M
Marshall Wace Exited
Millennium Management Exited
Point72 Asset Management Exited

Source: SEC EDGAR 13F filings

KYMR fails-to-deliver

SEC CNS data

On 30 Jun 2026, 211,145 shares of KYMR failed to deliver (about $23.1M) — the latest of 5 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
30 Jun 2026 211,145 $23.1M 0.257%
29 Jun 2026 62,868 $6.8M 0.076%
26 Jun 2026 384,238 $44.7M 0.467%
25 Jun 2026 6,938 $693K 0.008%
24 Jun 2026 85 $8K <0.001%
22 Jun 2026 30 $3K <0.001%
17 Jun 2026 466 $41K 0.001%
16 Jun 2026 2 $171 <0.001%

Source: SEC fails-to-deliver (CNS) data